Partner profile
CPC Biotech
Italian producer of analytical enzymes and ready-to-use microbiological soils for pharmaceutical, clinical chemistry and food & beverage quality control.
Arab Lab / CPC Biotech
CPC Biotech is an Italian SME founded in 2006, now one of the most important global players in the analytical-enzymes market. Products are developed in-house from gene cloning through final formulation, with some covered by trademark licence, and the company holds an exclusive supply agreement with Merck-Millipore.
In 2018, CPC Biotech acquired Neomed s.r.l.’s business unit for ready-to-use microbiological soils, consolidating its position by offering both enzymes and soils with enzymes already added.
The product range includes β-Lactamase CTZ, Amonisniper, Lactamator, β-Galactosidase, Glucose-6-Phosphate Dehydrogenase, Pyruvate Kinase and L-Lactate Dehydrogenase, serving quality control in the pharmaceutical, clinical chemistry and food & beverage fields.
At a glance
- Founded
- 2006 · Italy
- Partnership
- Exclusive supply agreement with Merck-Millipore
- Acquisition
- Neomed s.r.l. soils unit, 2018
Solves
Key capabilities
What CPC Biotech brings to the lab.
Analytical enzymes
Developed in-house from gene cloning through final formulation.
Ready-to-use microbiological soils
Soils with enzymes already added, from the Neomed business unit.
Product range
β-Lactamase CTZ, Amonisniper, Lactamator, β-Galactosidase, G6PDH, Pyruvate Kinase, L-LDH.
Quality control fields
Pharmaceutical, clinical chemistry and food & beverage.
Ready when you are
Talk to a specialist.
Tell us what the lab needs to measure, make or release. We route every request to the right Arab Lab department.